NED
NO EVIDENCE OF DISEASE

Our mission: cure cancer — and, eventually, the rest of chronic disease.

We build a clinical trial around one patient — a dedicated research team, continuous measurement, and every treatment option that exists, aimed at a single goal: finding what works to cure the patient. Every minute counts. NED removes the barriers standing between a patient and what might save them, so they can focus on healing.

Our collaborators come from Harvard Medical School · Massachusetts General Hospital · MD Anderson Cancer Center · UCLA · Cedars-Sinai · Weill Cornell
BARRIERS → SOLUTION

Barriers.

For a terminal patient, time, access, and operations all stand between them and what might work. NED removes those barriers directly — a small, elite unit that goes deep on one patient at a time, measures everything daily, and iterates fast, so the patient can focus on healing.

Time

10–20 years for a new treatment to reach patients. 3–6 months just to see if a scan shows progress. Terminal patients don't have that runway.

We measure hourly, daily, and scan weekly — adapting treatment as the data comes in, so we know what's working while it still matters.

Access

The best doctors, the newest protocols, the most promising research — scattered across institutions most patients will never reach.

We bring the world's best doctors, advanced research, and novel protocols to one patient together — no waiting list, no geography, just the most advanced care that exists.

Operations

Coordinating specialists, tracking results, financing care, managing diet, medication, and logistics — a full-time job most patients can't take on while they're sick.

A dedicated operations team runs all of it. Coordinating specialists, monitoring, logistics, and financing — so the patient's only job is healing.

HOW NED WORKS

Three steps, repeated until something works.

I

Strategy

An expert research team deep-dives into your medical information and builds a coherent plan, with clear reasoning behind every step.

II

Measurement

Dense daily datasets feed a live dashboard of your personal status and biology, to see treatment response much earlier.

III

Treatment

Standard and novel therapies, personalized and iterated according to state-of-the-art research, until we find what works for you.

THE INVERSION

Medicine studies thousands to find one average answer.

NED studies one patient, relentlessly, to find their answer — then lets it guide the next thousand.

ONE INTERVENTION
thousands of patients · years
ONE AVERAGE ANSWER
INVERT
ONE PATIENT
MANY INTERVENTIONS, MEASURED
formal n-of-1 studies
IN PRACTICE

Six months inside one patient.

-17%

Tumor metabolic activity, week-over-week — first patient, brain cancer. Alongside sustained low glucose / high ketones, improved sleep, and lower inflammation.

4 CHANGES IN 24 WEEKS · 120+ READINGS
NED
A
B
B+C
B+D
D+E
wk 0wk 4wk 8wk 12wk 16wk 20wk 24
TODAY
ONE THERAPY, UNCHANGED
↑ first scan                     first real decision ↑
FOUNDER & ALLIANCE
Eran Glicksman
Cancer survivor; co-founder & CTO of Masterschool (~$200M in sales last year, $100M seed)
Gordon Guyatt
Father of evidence-based medicine and author of the n-of-1 trial method (McMaster); ~680,000 citations, among the most cited researchers alive
Deborah Blumenthal
Director of Neuro-Oncology, Tel Aviv Sourasky Medical Center; fellowship-trained at Memorial Sloan Kettering; previously led Neuro-Oncology at the Huntsman Cancer Institute (University of Utah); 25+ years treating brain and CNS tumors
Ari Raphael, MD
Davidoff Cancer Center / Tel Aviv University — Head of Translational Oncology; leads development of CAR-T and TIL cell therapy programs for solid tumors

Our mission is you.

If you want to help us build this, write to us.

Please don’t include personal medical details here. We’ll follow up over a secure channel.